Daré Bioscience, Inc. to Present at the 2018 BIO Investor Forum
October 10 2018 - 8:00AM
Daré Bioscience, Inc. (NASDAQ: DARE), a clinical-stage, women’s
biopharmaceutical company, today announced that Sabrina Martucci
Johnson, President and Chief Executive Officer, will present at the
2018 BIO Investor Forum on Wednesday, October 17, 2018 at 3:00 p.m.
Pacific Time. Ms. Johnson will present a Daré overview and provide
an update on the Company’s portfolio programs.
The presentation will be webcast live and may be
accessed by visiting Daré’s website at
http://ir.darebioscience.com. A replay of the webcast will be
available for 10 business days.
About Daré Bioscience
Daré Bioscience is a clinical-stage biopharmaceutical company
committed to the advancement of innovative products for women’s
reproductive and sexual health. The company’s mission is to
identify, develop and bring to market a portfolio of novel,
differentiated therapies that expand treatment options, improve
outcomes and facilitate convenience for women in the areas of
contraception, vaginal health, sexual health, and fertility.
Daré’s product portfolio includes two potential first-in-class
candidates currently in clinical development: Ovaprene®, a
non-hormonal, monthly contraceptive vaginal ring, and Topical 5%
Sildenafil Citrate Cream, a potential treatment for female sexual
arousal disorder utilizing the same active ingredient as Viagra®.
To learn more about Daré’s full portfolio of women’s health
products, and mission to deliver novel therapies for women, please
visit www.darebioscience.com.
Daré may announce material information about its finances,
product candidates, clinical trials and other matters using its
investor relations website (http://ir.darebioscience.com), SEC
filings, press releases, public conference calls and
webcasts. Daré uses these channels to communicate with its
investors and the public about the company and other issues. The
information Daré posts on its investor relations website may be
deemed to be material information. Daré encourages investors, the
media, and others interested in the company to review the
information Daré posts on its investor relations website.
Contacts:
Investors on behalf of Daré Bioscience, Inc.:Ami BavishiBurns
McClellanabavishi@burnsmc.com212-213-0006
OR
Media on behalf of Daré Bioscience, Inc.:Amanda GuisbondCanale
Communicationsamanda@canalecomm.com781-405-8775
Source: Daré Bioscience
Dare Bioscience (NASDAQ:DARE)
Historical Stock Chart
From Mar 2024 to Apr 2024
Dare Bioscience (NASDAQ:DARE)
Historical Stock Chart
From Apr 2023 to Apr 2024